ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Change in substantial holding		14/02/23	145.9KB	Share
AVR	Notification of cessation of securities - AVR		10/02/23	23.52KB	Share
AVR	FDA Grants Expanded Approval for the DurAVR EFS	PRICE SENSITIVE	09/02/23	193.17KB	Share
AVR	Proposed issue of securities - AVR		09/02/23	33.65KB	Share
AVR	$35M Capital Raise	PRICE SENSITIVE	09/02/23	167.64KB	Share
AVR	Trading Halt	PRICE SENSITIVE	07/02/23	239.32KB	Share
AVR	Pause in Trading	PRICE SENSITIVE	07/02/23	116.79KB	Share
AVR	Notification regarding unquoted securities - AVR		06/02/23	29.44KB	Share
AVR	Proposed $50 Million Capital Facility	PRICE SENSITIVE	06/02/23	242.67KB	Share
AVR	Trading Halt	PRICE SENSITIVE	02/02/23	598.29KB	Share
AVR	Pause in Trading	PRICE SENSITIVE	02/02/23	116.09KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	290.43KB	Share
AVR	DurAVR First in Human Study 12 Month Results	PRICE SENSITIVE	16/01/23	185.98KB	Share
AVR	Notification of cessation of securities - AVR		20/12/22	23.57KB	Share
AVR	Cleansing Notice		02/12/22	159.69KB	Share
AVR	Application for quotation of securities - AVR		02/12/22	26.82KB	Share
AVR	Notification of cessation of securities - AVR		02/12/22	22.96KB	Share
AVR	FDA Approves Early Feasibility Study for DurAVR THV System	PRICE SENSITIVE	28/11/22	171.92KB	Share
AVR	Anteris DurAVR Comparative Study - PCR London Valves		28/11/22	190.3KB	Share
AVR	Anteris DurAVR presented at PCR London Valves		28/11/22	196.34KB	Share
AVR	Notification regarding unquoted securities - AVR		01/11/22	29.42KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/22	319.67KB	Share
AVR	R&D Refund		10/10/22	166.41KB	Share
AVR	Notification of cessation of securities - AVR		27/09/22	22.9KB	Share
AVR	Notification regarding unquoted securities - AVR		23/09/22	30.13KB	Share
AVR	Notification of cessation of securities - AVR		23/09/22	23.4KB	Share
AVR	Anteris Investor Webinar		20/09/22	4.33MB	Share
AVR	DurAVR FIH 30-Day Study Results Presented at TCT Boston		19/09/22	173.12KB	Share
AVR	Results Demonstrating Restoration of Normal Pre-Disease Flow	PRICE SENSITIVE	19/09/22	165.97KB	Share
AVR	Transcatheter Cardiovascular Therapeutics Conference		13/09/22	236.08KB	Share
AVR	Anteris Hosts Australian Interventional Cardiology Experts		05/09/22	145.51KB	Share
AVR	Cleansing Notice		30/08/22	157.89KB	Share
AVR	Application for quotation of securities - AVR		30/08/22	26.8KB	Share
AVR	Cleansing Notice		24/08/22	158.95KB	Share
AVR	Appendix 4D and Half Year Financial Report Announcement	PRICE SENSITIVE	24/08/22	174.21KB	Share
AVR	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/08/22	620.54KB	Share
AVR	Application for quotation of securities - AVR		24/08/22	26.81KB	Share
AVR	Cleansing Notice		18/08/22	159.51KB	Share
AVR	Application for quotation of securities - AVR		18/08/22	29.49KB	Share
AVR	Change in substantial holding		08/08/22	1.92MB	Share
AVR	Notification of cessation of securities - AVR		05/08/22	22.89KB	Share
AVR	Cleansing Notice		03/08/22	159.93KB	Share
AVR	Application for quotation of securities - AVR		02/08/22	32.25KB	Share
AVR	Third Conversion of Securities - Mercer		02/08/22	162.67KB	Share
AVR	Appendix 4C Clarification and Upcoming Milestones	PRICE SENSITIVE	27/07/22	176.33KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/22	317.11KB	Share
AVR	Dr. Martin Leon, MD Joins Global Medical Advisory Board		12/07/22	151.36KB	Share
AVR	Update on First In Human DurAVR THV Study	PRICE SENSITIVE	11/07/22	188.91KB	Share
AVR	Cleansing Notice		05/07/22	159.89KB	Share
AVR	Application for quotation of securities - AVR		05/07/22	29.52KB	Share
AVR	Notification regarding unquoted securities - AVR		30/06/22	29.43KB	Share
AVR	Notification of cessation of securities - AVR		30/06/22	22.93KB	Share
AVR	Application for quotation of securities - AVR		23/06/22	29.71KB	Share
AVR	DurAVR First In Human Patient 6 Month Study Follow Up	PRICE SENSITIVE	21/06/22	166.17KB	Share
AVR	Cleansing Notice		17/06/22	159.76KB	Share
AVR	Application for quotation of securities - AVR		17/06/22	36.19KB	Share
AVR	Change of Director's Interest Notice x4		17/06/22	344.78KB	Share
AVR	Notification regarding unquoted securities - AVR		17/06/22	36.55KB	Share
AVR	Cleansing Notice		10/06/22	158.86KB	Share
AVR	Application for quotation of securities - AVR		10/06/22	33.42KB	Share
AVR	Application for quotation of securities - AVR		02/06/22	26.74KB	Share
AVR	Second Conversion of Securities - Mercer		01/06/22	162.6KB	Share
AVR	Successful Completion of Second First-In-Human Study	PRICE SENSITIVE	31/05/22	168.24KB	Share
AVR	EXPANSION OF FIRST IN HUMAN TRIAL	PRICE SENSITIVE	25/05/22	207.03KB	Share
AVR	Results of Meeting		25/05/22	193.33KB	Share
AVR	AGM Chairman Address and CEO Presentation	PRICE SENSITIVE	25/05/22	14.92MB	Share
AVR	Expansion of Medical Advisory Board		24/05/22	141.33KB	Share
AVR	Application for quotation of securities - AVR		18/05/22	26.78KB	Share
AVR	Conversion of Securities - Mercer		18/05/22	209.09KB	Share
AVR	Notification of cessation of securities - AVR		16/05/22	23.43KB	Share
AVR	Cleansing Notice		05/05/22	159.75KB	Share
AVR	Application for quotation of securities - AVR		05/05/22	26.77KB	Share
AVR	Notification regarding unquoted securities - AVR		04/05/22	29.37KB	Share
AVR	Research Partnership with Yale University and YCRG		28/04/22	140.51KB	Share
AVR	Notice of General Meeting/Proxy Form		26/04/22	922.4KB	Share
AVR	Corporate Governance Statement and Appendix 4G		26/04/22	1.62MB	Share
AVR	Annual Report to shareholders		26/04/22	4.5MB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	21/04/22	313.33KB	Share
AVR	Notification of cessation of securities - AVR		14/04/22	23.42KB	Share
AVR	Notice of AGM and Director Nominations		31/03/22	137.12KB	Share
AVR	Cleansing Notice		30/03/22	160KB	Share
AVR	Application for quotation of securities - AVR		30/03/22	26.75KB	Share
AVR	Notification of cessation of securities - AVR		29/03/22	22.81KB	Share
AVR	Application for quotation of securities - AVR		21/03/22	26.86KB	Share
AVR	Cleansing Notice		14/03/22	160.24KB	Share
AVR	Notification of cessation of securities - AVR		11/03/22	23.42KB	Share
AVR	Application for quotation of securities - AVR		11/03/22	26.74KB	Share
AVR	Change of Director's Interest Notice		09/03/22	261.29KB	Share
AVR	Change in substantial holding		08/03/22	136.64KB	Share
AVR	Becoming a substantial holder		07/03/22	45.92KB	Share
AVR	Cleansing Notice		03/03/22	160.29KB	Share
AVR	Application for quotation of securities - AVR		03/03/22	26.74KB	Share
AVR	Application for quotation of securities - AVR		03/03/22	26.63KB	Share
AVR	Australian cardiologist joins Global Medical Advisory Board		03/03/22	165.78KB	Share
AVR	Proposed issue of securities - AVR		02/03/22	24.92KB	Share
AVR	USD 20M Placement - Perceptive Advisors	PRICE SENSITIVE	02/03/22	146.86KB	Share
AVR	Trading Halt	PRICE SENSITIVE	01/03/22	222.28KB	Share
AVR	Preliminary Final Report	PRICE SENSITIVE	25/02/22	1.16MB	Share
AVR	Change in substantial holding		24/02/22	136.59KB	Share
AVR	Cleansing Notice		23/02/22	159.76KB	Share

AVR Change in substantial holding
14/02/23		145.9KB	Share
AVR Notification of cessation of securities - AVR
10/02/23		23.52KB	Share
AVR FDA Grants Expanded Approval for the DurAVR EFS
09/02/23	PRICE SENSITIVE	193.17KB	Share
AVR Proposed issue of securities - AVR
09/02/23		33.65KB	Share
AVR $35M Capital Raise
09/02/23	PRICE SENSITIVE	167.64KB	Share
AVR Trading Halt
07/02/23	PRICE SENSITIVE	239.32KB	Share
AVR Pause in Trading
07/02/23	PRICE SENSITIVE	116.79KB	Share
AVR Notification regarding unquoted securities - AVR
06/02/23		29.44KB	Share
AVR Proposed $50 Million Capital Facility
06/02/23	PRICE SENSITIVE	242.67KB	Share
AVR Trading Halt
02/02/23	PRICE SENSITIVE	598.29KB	Share
AVR Pause in Trading
02/02/23	PRICE SENSITIVE	116.09KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	290.43KB	Share
AVR DurAVR First in Human Study 12 Month Results
16/01/23	PRICE SENSITIVE	185.98KB	Share
AVR Notification of cessation of securities - AVR
20/12/22		23.57KB	Share
AVR Cleansing Notice
02/12/22		159.69KB	Share
AVR Application for quotation of securities - AVR
02/12/22		26.82KB	Share
AVR Notification of cessation of securities - AVR
02/12/22		22.96KB	Share
AVR FDA Approves Early Feasibility Study for DurAVR THV System
28/11/22	PRICE SENSITIVE	171.92KB	Share
AVR Anteris DurAVR Comparative Study - PCR London Valves
28/11/22		190.3KB	Share
AVR Anteris DurAVR presented at PCR London Valves
28/11/22		196.34KB	Share
AVR Notification regarding unquoted securities - AVR
01/11/22		29.42KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
26/10/22	PRICE SENSITIVE	319.67KB	Share
AVR R&D Refund
10/10/22		166.41KB	Share
AVR Notification of cessation of securities - AVR
27/09/22		22.9KB	Share
AVR Notification regarding unquoted securities - AVR
23/09/22		30.13KB	Share
AVR Notification of cessation of securities - AVR
23/09/22		23.4KB	Share
AVR Anteris Investor Webinar
20/09/22		4.33MB	Share
AVR DurAVR FIH 30-Day Study Results Presented at TCT Boston
19/09/22		173.12KB	Share
AVR Results Demonstrating Restoration of Normal Pre-Disease Flow
19/09/22	PRICE SENSITIVE	165.97KB	Share
AVR Transcatheter Cardiovascular Therapeutics Conference
13/09/22		236.08KB	Share
AVR Anteris Hosts Australian Interventional Cardiology Experts
05/09/22		145.51KB	Share
AVR Cleansing Notice
30/08/22		157.89KB	Share
AVR Application for quotation of securities - AVR
30/08/22		26.8KB	Share
AVR Cleansing Notice
24/08/22		158.95KB	Share
AVR Appendix 4D and Half Year Financial Report Announcement
24/08/22	PRICE SENSITIVE	174.21KB	Share
AVR Appendix 4D and Half Year Financial Report
24/08/22	PRICE SENSITIVE	620.54KB	Share
AVR Application for quotation of securities - AVR
24/08/22		26.81KB	Share
AVR Cleansing Notice
18/08/22		159.51KB	Share
AVR Application for quotation of securities - AVR
18/08/22		29.49KB	Share
AVR Change in substantial holding
08/08/22		1.92MB	Share
AVR Notification of cessation of securities - AVR
05/08/22		22.89KB	Share
AVR Cleansing Notice
03/08/22		159.93KB	Share
AVR Application for quotation of securities - AVR
02/08/22		32.25KB	Share
AVR Third Conversion of Securities - Mercer
02/08/22		162.67KB	Share
AVR Appendix 4C Clarification and Upcoming Milestones
27/07/22	PRICE SENSITIVE	176.33KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
25/07/22	PRICE SENSITIVE	317.11KB	Share
AVR Dr. Martin Leon, MD Joins Global Medical Advisory Board
12/07/22		151.36KB	Share
AVR Update on First In Human DurAVR THV Study
11/07/22	PRICE SENSITIVE	188.91KB	Share
AVR Cleansing Notice
05/07/22		159.89KB	Share
AVR Application for quotation of securities - AVR
05/07/22		29.52KB	Share
AVR Notification regarding unquoted securities - AVR
30/06/22		29.43KB	Share
AVR Notification of cessation of securities - AVR
30/06/22		22.93KB	Share
AVR Application for quotation of securities - AVR
23/06/22		29.71KB	Share
AVR DurAVR First In Human Patient 6 Month Study Follow Up
21/06/22	PRICE SENSITIVE	166.17KB	Share
AVR Cleansing Notice
17/06/22		159.76KB	Share
AVR Application for quotation of securities - AVR
17/06/22		36.19KB	Share
AVR Change of Director's Interest Notice x4
17/06/22		344.78KB	Share
AVR Notification regarding unquoted securities - AVR
17/06/22		36.55KB	Share
AVR Cleansing Notice
10/06/22		158.86KB	Share
AVR Application for quotation of securities - AVR
10/06/22		33.42KB	Share
AVR Application for quotation of securities - AVR
02/06/22		26.74KB	Share
AVR Second Conversion of Securities - Mercer
01/06/22		162.6KB	Share
AVR Successful Completion of Second First-In-Human Study
31/05/22	PRICE SENSITIVE	168.24KB	Share
AVR EXPANSION OF FIRST IN HUMAN TRIAL
25/05/22	PRICE SENSITIVE	207.03KB	Share
AVR Results of Meeting
25/05/22		193.33KB	Share
AVR AGM Chairman Address and CEO Presentation
25/05/22	PRICE SENSITIVE	14.92MB	Share
AVR Expansion of Medical Advisory Board
24/05/22		141.33KB	Share
AVR Application for quotation of securities - AVR
18/05/22		26.78KB	Share
AVR Conversion of Securities - Mercer
18/05/22		209.09KB	Share
AVR Notification of cessation of securities - AVR
16/05/22		23.43KB	Share
AVR Cleansing Notice
05/05/22		159.75KB	Share
AVR Application for quotation of securities - AVR
05/05/22		26.77KB	Share
AVR Notification regarding unquoted securities - AVR
04/05/22		29.37KB	Share
AVR Research Partnership with Yale University and YCRG
28/04/22		140.51KB	Share
AVR Notice of General Meeting/Proxy Form
26/04/22		922.4KB	Share
AVR Corporate Governance Statement and Appendix 4G
26/04/22		1.62MB	Share
AVR Annual Report to shareholders
26/04/22		4.5MB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
21/04/22	PRICE SENSITIVE	313.33KB	Share
AVR Notification of cessation of securities - AVR
14/04/22		23.42KB	Share
AVR Notice of AGM and Director Nominations
31/03/22		137.12KB	Share
AVR Cleansing Notice
30/03/22		160KB	Share
AVR Application for quotation of securities - AVR
30/03/22		26.75KB	Share
AVR Notification of cessation of securities - AVR
29/03/22		22.81KB	Share
AVR Application for quotation of securities - AVR
21/03/22		26.86KB	Share
AVR Cleansing Notice
14/03/22		160.24KB	Share
AVR Notification of cessation of securities - AVR
11/03/22		23.42KB	Share
AVR Application for quotation of securities - AVR
11/03/22		26.74KB	Share
AVR Change of Director's Interest Notice
09/03/22		261.29KB	Share
AVR Change in substantial holding
08/03/22		136.64KB	Share
AVR Becoming a substantial holder
07/03/22		45.92KB	Share
AVR Cleansing Notice
03/03/22		160.29KB	Share
AVR Application for quotation of securities - AVR
03/03/22		26.74KB	Share
AVR Application for quotation of securities - AVR
03/03/22		26.63KB	Share
AVR Australian cardiologist joins Global Medical Advisory Board
03/03/22		165.78KB	Share
AVR Proposed issue of securities - AVR
02/03/22		24.92KB	Share
AVR USD 20M Placement - Perceptive Advisors
02/03/22	PRICE SENSITIVE	146.86KB	Share
AVR Trading Halt
01/03/22	PRICE SENSITIVE	222.28KB	Share
AVR Preliminary Final Report
25/02/22	PRICE SENSITIVE	1.16MB	Share
AVR Change in substantial holding
24/02/22		136.59KB	Share
AVR Cleansing Notice
23/02/22		159.76KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	920	5.270
1	613	5.240
1	576	5.200
1	20000	5.150

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)


Last $5.59		Change 0.330 ( 4.68 %)
Open	High	Low	Volume
$5.59	$5.59	$5.29	3526
Last updated 15.28pm 22/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Corporate Spotlight
Not Yet Available